August 03, 2021
A Pennsylvania federal court has given its final approval to an $8.5 million settlement between Trevena Inc. and investors who say the biopharmaceutical company misled them about federal approvals for a morphine alternative.
May 29, 2019
Block & Leviton LLP and Kaufman Coren & Ress LLP were named class counsel in litigation accusing Trevena Inc. of artificially inflating its share value, a Pennsylvania federal judge decided on Wednesday, citing careless errors made by an investor represented by rival attorneys.
October 16, 2018
Shareholders filed a proposed class action lawsuit against Trevena Inc. in Pennsylvania federal court Monday, alleging that the company and its officers misled investors about the U.S. Food and Drug Administration's prospects for approving the company's morphine alternative.